Kaley. In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am. J. Physiol. Heart Circ. Physiol. 278: H762-H768, 2000.-The mechanisms that account for acetylcholine (ACh)-induced responses of skeletal muscle arterioles of mice lacking endothelial nitric oxide (NO) synthase (eNOS-KO) were investigated. Isolated, cannulated, and pressurized arterioles of gracilis muscle from male eNOS-KO (74.1 Ϯ 2.3 µm) and wild-type (WT, 87.2 Ϯ 2.1 µm) mice developed spontaneous tone accounting for 63 and 61% of their passive diameter (116.8 Ϯ 3.4 vs. 143.2 Ϯ 2.8 µm, respectively) and dilated dose-dependently to ACh (10 Ϫ9 -10 Ϫ7 M). These dilations were significantly smaller in vessels of eNOS-KO compared with WT mice (29.2 Ϯ 2.0 µm vs. 46.3 Ϯ 2.1 µm, at maximum concentration) but responses to the NO donor, sodium nitrite (NaNO 2 , 10 Ϫ6 -3 ϫ 10 Ϫ5 M), were comparable in the vessels of the two strains. N G -nitro-L-arginine (L-NNA, 10 Ϫ4 M), an inhibitor of eNOS, inhibited AChinduced dilations by 60-90% in arterioles of WT mice but did not affect responses in those of eNOS-KO mice. In arterioles of eNOS-KO mice, dilations to ACh were not affected by indomethacin but were essentially abolished by inhibitors of cytochrome P-450, clotrimazole (CTZ, 2 ϫ 10 Ϫ6 M) or miconazole (MCZ, 2 ϫ 10 Ϫ6 M), as well as by either high K ϩ (40 mM) or iberiotoxin [10 Ϫ7 M, a blocker of Ca 2ϩ -dependent K ϩ channels (K Ca channels)]. On the other hand, in WT arterioles CTZ or MCZ inhibited ACh-induced dilations only by ϳ10% and only in the presence of L-NNA. These results indicate that in arterioles of eNOS-KO mice, endothelium-derived hyperpolarizing factor (EDHF), synthesized via cytochrome P-450, accounts entirely for the mediation of ACh-induced dilation via an increase in K Ca -channel activity. In contrast, in arterioles of WT mice, endothelium-derived NO predominantly mediates ACh-induced dilation in which participation of EDHF becomes apparent only after inhibition of NO synthesis. nitric oxide; endothelium; cytochrome P-450; potassium channels; arteriolar smooth muscle THE MECHANISMS INVOLVED in endothelium-dependent vascular responses to acetylcholine (ACh) have been well documented since the original report of Furchgott
THE MECHANISMS INVOLVED in endothelium-dependent vascular responses to acetylcholine (ACh) have been well documented since the original report of Furchgott and Zawadzki in 1980 (12) . In addition to nitric oxide (NO), endothelium-derived membrane hyperpolarization of vascular smooth muscle, first described by Bolton et al. in 1984 (4) , is now thought to contribute to the vasodilation to ACh. The chemical identity of the endothelium-derived hyperpolarizing factor (EDHF), thus far, remains elusive. The response to ACh, mediated by muscarinic receptors and initiating a calcium influx into endothelial cells, involves not only the stimulation of endothelial nitric oxide synthase (NOS) resulting in NO-mediated vasodilation, but also the activation of endothelial phospholipase A 2 (PLA 2 ), causing the release of arachidonic acid from the cell membrane (17) . Arachidonic acid may then be metabolized by cytochrome P-450 monooxygenase (P-450), as well as by cyclooxygenase or lipoxygenase, to substances that serve as paracrine and autocrine regulators of vascular tone (16, 26) . Certain metabolites of cytochrome P-450-epoxygenase [e.g., epoxyeicosatrienoic acids; (EETs)] can elicit vasodilation by hyperpolarizing vascular smooth muscle cells (5) and thus could serve the function of an EDHF.
The principal endothelium-derived vasoactive mediators, NO, prostaglandins, and EDHF, contribute differently to ACh-induced dilation dependent on the vascular bed (1, 13, 20) , size of the vessel (30) , and pathophysiological condition studied (2, 23, 28) . In resistance arteries, the contribution of EDHF to endothelium-dependent vasodilation may be more pronounced than in large vessels (13, 30) . These mediators seem to be interrelated, but whether they share common mechanisms of action and whether one reinforces or otherwise modulates the action of the others is still an open question (2, 22, 33) . Thus the purpose of the present study was to elucidate the mechanisms by which ACh elicits arteriolar dilation via alternative pathways determined by the presence or absence of endothelial NOS (eNOS). Although the reduction or absence of responses to ACh have already been observed in carotid (7, 11) , cerebral (34) , aortic (7, 19) , pulmonary (31) , coronary (7, 15) , and mesenteric arteries (7) of eNOS-deficient mice, such investigation on skeletal muscle microvessels has not as yet been carried out. We hypothesized that although the endothelial mediation of arteriolar responses to ACh may be altered in eNOS knockout (KO) mice, other mechanisms or mediators would compensate for the absence
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
of NO, providing for the maintenance of responses to ACh. Thus we aimed to identify and contrast the endothelial mediators responsible for ACh-induced dilation in gracilis muscle arterioles of male eNOS-KO and corresponding wild-type (WT) mice and furthermore to characterize the nature of the vascular alterations induced by eNOS deficiency.
METHODS

Animals.
Heterozygous eNOS (ϩ/Ϫ) mice, originally developed by Shesely et al. (29) , were interbred to generate eNOS WT (ϩ/ϩ) and homozygous mutant (Ϫ/Ϫ) mice. Mice were genotyped by Southern analysis of DNA as described previously (29) Experimental setup. Experiments were conducted on isolated first-order gracilis muscle arterioles of WT and eNOS-KO mice. Mice were killed by cervical dislocation. The dissection and isolation of vessels were similar to what were described earlier for rats (32) . A segment, about 1 mm in length, of an arteriole was isolated and cannulated by two glass pipettes in a vessel chamber (1 ml in volume) and suffused (1 ml/min) with physiological salt solution (PSS) containing (in mmol/l) 118.0 NaCl, 5.0 KCl, 2. In the second series of experiments, the role of metabolites of cytochrome P-450 in ACh-induced dilations was assessed by using clotrimazole (CTZ, 2 ϫ 10 Ϫ6 M) or miconazole (MCZ, 2 ϫ 10 Ϫ6 M), inhibitors of cytochrome P-450 (6, 16) . After control experiments, the inhibitors were administered for 30 min either alone or in the presence of L-NNA, and then responses to ACh were reassessed.
In the third series of experiments, the contribution of EDHF to the responses to ACh were evaluated by performing the experiments in the presence of a high extracellular concentration of K ϩ (40 mM), an established technique to test the effect of K ϩ channels on vascular responses, or in the presence of iberiotoxin (IBTX, 10 Ϫ7 M), a blocker of Ca 2ϩ -dependent K ϩ channels (K Ca ). Vessels were suffused with high-K ϩ PSS for 10 min after control experiments, and the responses to ACh were once more tested. After recovery from the effects of high K ϩ by resuffusing the vessels with normal PSS, the experiments were repeated once more before and after administration of IBTX. In separate experiments, the role of prostaglandins in ACh-induced dilation of eNOSdeficient arterioles was tested by using indomethacin (10 Ϫ5 M) to inhibit cyclooxygenase. After incubation with indomethacin for 30 min, the responses to ACh were reassessed. Arteriolar responses to acidic sodium nitrite (NaNO 2 , 10 Ϫ6 , 10 Ϫ5 , and 3 ϫ 10 Ϫ5 M) were determined in both strains of mice.
Passive diameter. To assess the active tone generated by arterioles in response to intravascular pressure, as well as to normalize the changes in diameter in response to the agents, at the conclusion of each experiment, the suffusion solution was changed to a Ca 2ϩ -free PSS containing 1 mM EGTA. The vessels were incubated for 10 min, and then the passive diameter of arterioles at 80 mmHg perfusion pressure was obtained.
Chemicals. All chemicals were obtained from Sigma (St. Louis, MO), except for L-NNA and ODQ, which were obtained from Aldrich Chemical (Milwaukee, WI) and Cayman Chemical (Ann Arbor, MI), respectively. L-NNA (10 Ϫ2 M) was dissolved in saline with sonication. Indomethacin, ODQ, CTZ, and MCZ were dissolved in DMSO, at the concentration of 10 Ϫ1 M (for indomethacin and ODQ) and 10 Ϫ2 M (for CTZ and MCZ), respectively, and further diluted with PSS. The highest concentration of DMSO in the chamber was 0.1% (vol/vol), which had no effect on vessel tone. NaNO 2 was prepared similar to what was described earlier (32) . All other agents were dissolved in distilled water. Drugs were freshly prepared on the day of experiments.
Statistics. The data are presented as means Ϯ SE. Peak changes in diameter were expressed as percent of passive diameter. N and n are the numbers of mice and vessels, respectively. When two or more vessels were studied from one animal, their responses were averaged. Statistical significance was calculated by repeated measures of ANOVA followed by Tukey post hoc multiple-comparison test. Student's t-test was also used as appropriate. Significance level was taken at P Ͻ 0.05.
RESULTS
The characteristics of arterioles of WT and eNOS-KO mice are shown in the Table 1 . Both active and passive diameters were significantly smaller in arterioles of eNOS-KO than in those of WT mice, whereas their basal tone, expressed as percentage of passive diameter, were comparable.
Peak changes in diameter, as a percentage of passive diameter, in response to various concentrations of ACh and NaNO 2 are summarized in Fig. 1 . ACh-induced concentration-dependent dilation of arterioles of eNOS-KO mice was significantly smaller at each concentration (by ϳ30%) than that of WT mice (Fig. 1A) . Arteriolar dila- tions to NaNO 2 , however, were not different (Fig. 1B) in vessels of the two strains of mice.
To characterize the endothelial mediators that contribute to ACh-induced dilation, inhibitors that block the NO-cGMP pathway, cyclooxygenase, cytochrome P-450-epoxygenase, or K ϩ channels, were used. Figure  2 shows that in WT arterioles, L-NNA significantly inhibited arteriolar dilations to ACh by ϳ90 to 60%, at increasing concentrations ( Fig. 2A) . ODQ had a similar inhibitory effect on the responses (Fig. 2B) . Next, the possible role of cytochrome P-450 metabolites in the ACh-induced dilation in WT arterioles was tested. Figure 3 demonstrates that MCZ (Fig. 3A) or high K ϩ (Fig. 3B ) alone did not affect responses to ACh which, however, were eliminated if in the presence of MCZ additional L-NNA was given (Fig. 4A) . Moreover, the residual portion of ACh-induced dilation in the presence of L-NNA (shown in Fig. 2A ) was essentially abolished by additional administration of CTZ (Fig. 4B,  10 .6 Ϯ 2.5 µm before vs. 3.3 Ϯ 2.1 µm after CTZ, P Ͻ 0.05, at maximun concentration of ACh).
In arterioles of eNOS-KO mice, ACh-induced dilations were independent of NO and prostaglandins since L-NNA and indomethacin did not affect responses (Fig.  5) . However, these dilations were essentially eliminated by CTZ (Fig. 6A) or MCZ (Fig. 6B) , indicating that the cytochrome P-450-epoxygenase pathway is involved in the mediation of the response to ACh.
Furthermore, when vessels were exposed to high K ϩ , known to depolarize vascular smooth muscle, dilations to ACh were essentially eliminated (Fig. 7) . After recovery of responses, IBTX also abolished the dilations (Fig. 7) , indicating that in arterioles of eNOS-KO mice, EDHF mediates ACh-induced dilations via activation of K Ca channels.
DISCUSSION
The present study demonstrates that ACh causes dilation of skeletal muscle arterioles from mice deficient in the expression of the gene for eNOS. The somewhat attenuated dilator response to ACh, compared with that in arterioles of WT mice, is primarily mediated by metabolites of cytochrome P-450-epoxygenase, which could be viewed as an EDHF. In WT mice, arteriolar dilations to ACh are predominantly mediated by endothelial NO. To our understanding, this is the first demonstration of a role for EDHF in the mediation of vascular responses to ACh in mice.
Previous studies demonstrated a tissue-specific vascular response to ACh in eNOS-mutant mice. For instance, vasodilation elicited by ACh, which is mediated by endothelial NO in WT vessels, is absent in eNOS-deficient carotid (7, 11) , aortic (7, 19) , coronary (7), and pulmonary arteries (31) . In pial arterioles, neuronal NOS compensates for the loss of eNOS and seems to be responsible for the maintained ACh- induced dilations (34) . Moreover, a cyclooxygenasedependent component, which partially mediates AChinduced dilations in coronary (15) and mesenteric (7) arteries of WT mice, accounts solely for the mediation of responses in the corresponding vessels of eNOSdeficient mice.
ACh-induced dilations mediated by EDHF have been observed in a variety of vessels, including porcine coronary artery (18) , carotid and aortic arteries of rabbit (9) , and aorta and pulmonary arteries of the rat (8). EETs previously have been shown to elicit dilator responses in renal, cerebral, coronary, and caudal arteries via activation of K Ca channels, as demonstrated by patch-clamp studies (14, 36) and by the findings that either tetraethylammonium or charybdotoxin (5, 17) inhibited the responses. Thus the fact that EETs are formed in endothelial cells and serve as vasodilators, with the capacity of hyperpolarizing vascular smooth muscle by opening K ϩ channels, make them attractive candidates for being considered as EDHF.
A recent study demonstrates the presence of an EDHF-like activity in response to ␣ 2 -adrenergic receptor stimulation in mesenteric arteries of eNOS-deficient mice (33) . Also, in carotid arteries of hypercholesterolemic rabbits, perhaps as a result of the interruption in the NO-cGMP signaling pathway, the maintained ACh-induced dilations, unlike those in normal arteries, were inhibited by increased extracellular potassium or charybdotoxin (23) . In L-NNA-diclofenac-treated carotid arteries of rabbits, ACh-elicited dilations could be either abolished by the inhibition of K Ca channels or attenuated by a NO donor which, however, failed to affect the responses in control (untreated) vessels, indicating that NO may exert a feedback inhibition on EDHF formation (13) . A similar effect of a NO donor on bradykinin-induced EDHF-mediated dilations of porcine coronary artery, treated with inhibitors of eNOS and cyclooxygenase, was also observed (2) . Based on these findings, it is plausible to speculate that in the absence of endothelial NO, ACh may stimulate an endothelial cytochrome P-450 metabolic pathway and hyperpolarize vascular smooth muscle to mediate the vasodilator response. In view of the fact that a hyperpolarizing current may spread from endothelial to smooth muscle cells, the physiological significance of electrical coupling between them assumes greater significance in the microcirculation, where contacts between the two cell types are much more intimate than in large vessels. Indeed, direct heterocellular gap junctional communication between endothelium and smooth muscle may play a crucial role in the transfer of EDHF in response to ACh-elicited relaxation of rabbit mesenteric artery (20) .
Endothelial mediators contributing to ACh-induced dilation in arterioles of WT mice. Vasodilation to ACh in arterioles of WT mice is mediated primarily by the activation of endothelial NO-cGMP pathway, as indicated by the significant inhibition of the response after administration of L-NNA or ODQ. In the presence of L-NNA, the non-NO-mediated portion of the response ( Fig. 2A) was practically eliminated by additional administration of CTZ (Fig. 4B) , suggesting that the cytochrome P-450 pathway can also participate in ACh-induced dilations in arterioles of normal mice, albeit to a much lesser degree than the NOS pathway. Our results suggest that cytochrome P-450-EDHFmediated responses become apparent only after inhibition of NO synthesis, suggesting that EDHF may serve as a back-up mechanism when NO is absent. A similar phenomenon also has been observed regarding the participation of NO and prostaglandins in the AChinduced dilations in mesenteric artery of eNOS-WT mice (7) . Data depicted in the results shown in Fig. 3B could also serve as an indication that the NO-mediated dilations to ACh are not mediated by K Ca channels, as reported by others (3), but rather by stimulation of cGMP synthesis.
In the present study it also was found that the inhibitory effect of L-NNA on the NO-mediated dilations decreased as the concentration of ACh increased ( Fig. 2A) . Previous studies have demonstrated that both NO and EDHF synthesis in response to a variety of stimuli appears to be dependent on an increase in the intracellular concentration of Ca 2ϩ and the formation of a Ca 2ϩ -calmodulin complex (21) . It also was noted that endothelium-dependent hyperpolarization in many instances requires a higher concentration of agonists than what is necessary to induce NO-dependent relaxation (22) . Indeed, a greater intracellular Ca 2ϩ concentration threshold for prostacyclin formation than that required for NO synthesis in endothelial cells has been described (24) . On the basis of these findings, the inverse relationship between the concentration of ACh and the inhibitory effect of L-NNA observed can be the result of the fact that eNOS is more sensitive to Ca 2ϩ than PLA 2 . Therefore, lower doses of ACh seem to stimulate mainly the L-arginine-NO pathway; higher doses, however, may simultaneously activate the PLA 2 -cytochrome P-450 pathway. EDHF contributing to ACh-induced dilation in arterioles of eNOS-KO mice. ACh elicited dilations in arterioles of eNOS-KO mice, although the responses were significantly smaller than in those of WT mice (Fig. 1A) . Because of the comparable responses to NaNO 2 in the two groups of arterioles (Fig. 1B) , it is unlikely that a limited dilator capacity, due to the significantly smaller active and passive diameter of arterioles of eNOS-KO than in those of WT mice (Table 1) , is responsible for the attenuated dilation to ACh, although the reduced diameter may be an alteration that favors an increase in peripheral resistance and consequently elevated blood pressure (29) . The reduced ACh-induced dilations were inhibited (by ϳ80-90%) by CTZ or MCZ (Fig. 6) , revealing a primary role for a cytochrome P-450 metabolite in the response to ACh in skeletal muscle arterioles of eNOS-deficient mice. As mentioned previously, metabolites of cytochrome P-450-EDHF played only a minor role (ϳ10%) in the mediation of dilation to ACh in L-NNA-treated WT arterioles. Their role, however, was dramatically augmented in response to a genetic lack of NO, as CTZ inhibited ACh-induced dilations by ϳ1-6 µm in arterioles of WT ( Figs. 2A and 4B ) and 4-20 µm in those of eNOS-KO (Fig. 6A) mice, accounting for ϳ10 and 85% of control responses, respectively. MCZ (Fig. 6B) , a more selective inhibitor of cytochrome P-450 epoxygenase, responsible for converting arachidonic acid to EETs, exhibited an inhibitory effect similar to CTZ, supporting further the evidence that the endothelial mediators accounting for the responses are most likely EETs. However, there is evidence showing that in some tissues, e.g., in rabbit cerebral arteriole (10) , the dilator responses to EETs are dependent on their metabolism via cyclooxygenase, as indicated by the inhibition of the responses after indomethacin administration. Thus although plausible candidates for EDHF, EETs by eliciting vasodilation do not define EDHF activity unequivocally unless they also hyperpolarize smooth muscle. On the other hand, as the result of activation of PLA 2 by ACh, arachidonic acid can also be metabolized by cyclooxygenase, leading to a prostaglandin-dependent dilation. To address these issues, the effects of indomethacin, high K ϩ , and IBTX on the ACh-induced cytochrome P-450-mediated dilations of eNOS-KO arterioles were determined. The results show that the responses to ACh were not affected by indomethacin (Fig. 5B) , suggesting a cyclooxygenaseindependent response. Also, high K ϩ , which did not affect the responses in WT arterioles (Fig. 3B) prevented ACh-induced dilations in those of eNOS-KO mice (Fig. 7) , indicating that the response to ACh in eNOS-KO arterioles is primarily based on hyperpolarization of vascular smooth muscle. Moreover, dilations to ACh were also abolished by IBTX (Fig. 7) , confirming further our conclusion that the cytochrome P-450-mediated dilation to ACh in arterioles of eNOS-KO mice is dependent on hyperpolarization of smooth muscle, via activation of K Ca channels. There still exists the possibility that EDHFs other than EETs could, via the same mechanism, contribute to the ACh-induced vasodilation.
Although it is still unclear whether EDHF is constitutively synthesized in endothelial cells or becomes functional only after the suppression of the synthesis of other vasodilator mediators (i.e., NO and prostaglandins), an augmented role for EDHF in eNOS-KO mice has been demonstrated in the present study. Also, in stenosed canine coronary arteries (28) and cholesterolfed rabbit aorta (25) , the synthesis of EETs has been reported to be increased. An EDHF-mediated pathway was described in mesenteric artery of eNOS-KO mice, which was thought to be activated by the absence of NO (33) . Recently, inhibition of ACh-induced hyperpolarization by endothelial prostacyclin in guinea pig coronary artery has been reported (35) . Consistent with these findings, we found that in WT arterioles EDHF participates in ACh-induced dilation to a significant degree only in the presence of L-NNA. However, in eNOS-KO arterioles, EDHF is the primary contributor to the responses to ACh. Our results also suggest that under physiological conditions, the synthesis of EDHF is inhibited by NO. In the absence of NO, EDHF serves as a back-up mechanism and subserves a major role in the mediation of ACh-induced dilation.
With respect to the mechanisms by which NO modulates the production of EDHF, one possibility is that by binding to the heme group of P-450 reductase, a cofactor required for activation of P-450 enzymes (16) , NO inactivates the enzyme. Alternatively, it is possible that some isozymes of P-450, which are not or perhaps only little expressed constitutively, can be induced in response to metabolic or hormonal changes in vivo. This hypothesis is supported by the evidence that steroid hormones induce P-450 4A gene expression, resulting in a significant increase in P-450 4A enzyme activity in the lungs of pregnant animals (27) .
The data from the present study, obtained by means of a pharmacological approach, support our hypothesis that a compensatory enhanced production of EDHF, that activates K Ca channels, is the primary mediator of ACh-induced dilations in arterioles of eNOS-KO mice. This finding may be of pathophysiological significance for the regulation of vascular function in the absence or reduction of endothelial NO synthesis.
